Thank you Nick. That is interesting color. I do not doubt it, because we know how there is a whole industry of people looking to downplay every aspect of this trial non-stop, going month after month, raising the same issues over and over again. It's important to be able to point to more than a press release. Those people can really undermine a company, but they are not as credible as a peer reviewed journal. And that is a fact. And that will likely be enough one might hope to ensure that potential partners and or acquiring companies do not have to worry that the market will second guess whatever price they may decide is required. Just IMHO.
News 
Market Data 
Discover 
